08/13/2024
3:42 PM | aTYR PHARMA INC (Filer)
Atyr PHARMA (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/24/2024
4:29 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
SCHIMMEL PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:30 AM | aTYR PHARMA INC (Filer)
Atyr PHARMA (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
7:26 AM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
DENYES NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:34 AM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:38 AM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:27 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Gross Jane A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/23/2024
6:30 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
CLARKE JOHN K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:07 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
COUGHLIN TIMOTHY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:11 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Zaknoen Sara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:16 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
SCHIMMEL PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:19 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Lucas Svetlana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:38 PM | aTYR PHARMA INC (Filer)
Atyr PHARMA (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
12:43 PM | aTYR PHARMA INC (Subject)
Atyr PHARMA (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | aTYR PHARMA INC (Subject)
Atyr PHARMA (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024
7:20 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:15 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
DENYES NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:18 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
9:17 AM | aTYR PHARMA INC (Subject)
Atyr PHARMA (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
| Form SC 13G/A | |
01/09/2024
6:35 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:30 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
DENYES NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:33 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
11:21 AM | aTYR PHARMA INC (Subject)
Atyr PHARMA (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G | |
12/12/2023
5:50 PM | aTYR PHARMA INC (Issuer)
Atyr PHARMA (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
11:15 PM | aTYR PHARMA INC (Filer)
Atyr PHARMA (Filer)
| Form EFFECT | |
09/26/2023
8:01 AM | aTYR PHARMA INC (Filer)
Atyr PHARMA (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
7:04 AM | aTYR PHARMA INC (Filer)
Atyr PHARMA (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
